Impact of Changing Definitions for Myocardial Infarction: A Report from the AMIS Registry

American Journal of Medicine

Volumn 121, Issue 12, 2008, Pages 1065-1071

  Urban, Philip ^a   Radovanovic, Dragana ^b   Erne, Paul ^c   Stauffer, Jean Christophe ^d   Pedrazzini, Giovanni ^e   Windecker, Stephan ^f   Bertel, Osmund ^g  

^a LA TOUR HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c LUZERNER KANTONSSPITAL   (Switzerland)

^d Hopital Cantonal de Fribourg   (Switzerland)

^e REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g KLINIK IM PARK   (Switzerland)

Author keywords

Acute coronary syndrome; Biomarkers; Coronary artery disease; Myocardial infarction; Troponin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REGISTER; ST SEGMENT ELEVATION; SWITZERLAND;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SWITZERLAND;

EID: 56349141057     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.08.020     Document Type: Article

References (23)

1. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Circulation 90 (1994) 583-612
2. Thiemann D.R., Coresh J., Oetgen W.J., and Powe N.R. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med 340 (1999) 1640-1648
3. Juul-Möller S., Edvardsson N., Jahnmatz B., et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 340 (1992) 1421-1425
4. Rogers W.J., Bowlby L.J., Chandra N.C., et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 90 (1994) 2103-2114
5. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
6. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
7. Roger V.L., Killian J.M., Weston S.A., et al. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 114 (2006) 790-797
8. Salomaa V., Koukkunen H., Ketonen M., et al. A new definition for myocardial infarction: what difference does it make?. Eur Heart J 26 (2005) 1719-1725
9. Erne P., Radovanovic D., Urban P., et al. Early drug therapy and in-hospital mortality following acute myocardial infarction. Heart Drug 3 (2003) 134-140
10. Fassa A.-A., Urban P., Radovanovic D., et al. Trends in reperfusion therapy of ST elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart 91 (2005) 882-888
11. Radovanovic D., Erne P., Urban P., et al. Gender differences in management and outcome in patients with acute coronary syndromes: results on 20290 patients from the AMIS Plus registry. Heart 93 (2007) 1369-1375
12. Schoenenberger A.G., Radovanovic D., Stauffer J.-C., et al. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J Am Geriatr Soc 56 (2008) 510-516
13. Berger A., Stauffer J.C., Radovanovic D., et al. Comparison of in-hospital mortality for acute myocardial infarction in Switzerland with admission during routine duty hours versus admission during out of hours (insight into the AMIS Plus Registry). Am J Cardiol 101 (2008) 422-427
14. Apple F.S., Jesse R.L., Newby K., Wu A.H.B., and Christenson R.H. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 53 (2007) 547-551
15. Tzivoni D., Koukoui D., Guetta V., et al. Comparison of troponin T to creatinine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol 101 (2008) 753-757
16. Hasdai D., Behar S., Boyko V., et al. Cardiac biomarkers and acute coronary syndromes-the Euro Heart Survey of Acute coronary syndromes experience. Eur Heart J 24 (2003) 1189-1194
17. Salomaa V., Ketonen M., Koukkunen H., et al. The effect of correcting for troponin on trends in conorary heart disease events in Finland during 1993-2002: the FINAMI study. Eur Heart J 27 (2006) 2394-2399
18. French J.K., and White H.D. Clinical implications of the new definition of myocardial infarction. Heart 90 (2000) 99-106
19. Fox K.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360 (2002) 743-751
20. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
21. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 327 (1992) 146-150
22. James S., Armstrong P., Califf R., et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 115 (2003) 241-244
23. Sabatine D.S., Morrow D.A., De Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1766